As of November 2024, Prestige BioPharma has a market cap of $608.99M. This makes Prestige BioPharma the world's 10247th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $381.19M | -10.86% |
2023 | $427.65M | 29.33% |
2022 | $330.66M | -64.84% |
2021 | $940.56M | - |